Last reviewed · How we verify
NCT05000814
Study of Cost-effectiveness of the Airway Management in Thoracic Surgery
trial testing DLT in Brief Description of Focus of Study Instead in 110 participants. Status unknown.
1 December 2025
Quick facts
| Lead sponsor | Hospital General Valencia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 30 November 2023 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 February 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- DLT
Conditions studied
- Brief Description of Focus of Study Instead — all drugs for Brief Description of Focus of Study Instead →
Sponsor
Hospital General Valencia
Who can join
Eligibility, any sex, with Brief Description of Focus of Study Instead. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators want to carry out a study to determine the role of Doble Lumen Tubes with built-in camera Viva Sight-DL (VDLT) in thoracic surgery. With this study the investigators want to study and enlarge the information in the different surgical approaches, including robotic surgery. The objective of this study is report a single-center experience using individual data costs to compare the cost effectiveness of VDLT Viva Sight versus the use of conventional Doble Lumen Tubes (cDLT) together with fiberoptic bronchoscope in patients undergoing thoracic surgery, in order to generate information for future decision making related to both devices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05000814
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of DLT
Trials testing the same drug.
- NCT03403192 — EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05000814 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital General Valencia
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05000814.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing